ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
나노캐리어 시장 규모는 최근 급속히 확대하고 있습니다. 2024년 97억 9,000만 달러에서 2025년에는 116억 1,000만 달러로 CAGR 18.5%로 확대합니다. 지난 기간 중의 성장은 만성질환 및 암 질환의 유병률 증가, 표적치료제 및 맞춤치료제 승인 확대, 국가적 예방접종 프로그램 및 부스터 계획의 확대, 바이오의약품 연구개발의 진전, 의료비 지출 증가 등에 기인하는 것으로 보입니다.
나노캐리어 시장 규모는 향후 수년간 급격한 성장이 예상됩니다. 2029년에는 CAGR 18.2%로 22억 6,670만 달러로 성장할 것입니다. 예측 기간 중의 성장은 고령화 인구 증가, 생활습관병 관련 질환의 지속적인 증가, 금속 및 금속산화물 입자의 사용 증가, 맞춤형 의료에 대한 관심 증가, 임상시험 참여 확대 등에 기인할 것으로 보입니다. 예측 기간의 주요 동향으로는 헬스케어 기술의 발전, 개인 맞춤형 반응성 약물전달 시스템 구축, 자극에 반응하는 나노캐리어의 개발, 3D 프린팅 기술의 발전, 범용성 높은 나노캐리어 플랫폼의 출현 등이 있습니다.
나노캐리어는 약물, 유전자, 기타 치료제를 고정밀도로 운반하여 체내 표적 세포 및 조직에 도달할 수 있도록 특별히 고안된 나노 스케일 전달 시스템입니다. 이러한 캐리어는 치료 화합물의 안정성과 생체 이용률을 높이고, 제어된 서방형을 제공하며, 건강한 조직에 대한 노출을 제한하여 부작용의 위험을 줄입니다.
나노캐리어의 주요 카테고리에는 고분자 나노캐리어, 지질 기반 나노캐리어, 무기 나노캐리어 등이 있습니다. 고분자 나노캐리어는 약물이나 치료제를 체내 특정 부위에 효과적으로 전달하기 위해 만들어진 나노 스케일 고분자 기반 시스템입니다. 약물전달, 진단, 백신, 유전자 치료 등의 분야에 적용되어 제약회사, 생명공학 기업, 병원 및 클리닉, 연구기관 등의 최종사용자를 지원하고 있습니다.
2025년 봄, 미국의 갑작스러운 관세 인상과 이에 따른 무역 마찰은 제약회사에 심각한 영향을 미치고 있습니다. 이익이 적은 제네릭 의약품 제조업체는 특히 취약하며, 일부 기업은 수익성이 낮은 의약품의 생산을 축소하기도 합니다. 생명공학 기업은 관세와 관련된 특수 시약의 부족으로 인해 임상시험이 지연되고 있습니다. 이에 업계는 인도와 유럽에서 원료의약품 생산을 확대하고, 재고 비축을 늘리며, 필수의약품의 무역 면제를 요구하고 있습니다.
나노캐리어 시장 조사 보고서는 나노캐리어 산업 세계 시장 규모, 지역 점유율, 나노캐리어 시장 점유율을 가진 경쟁사, 상세한 나노캐리어 시장 부문, 시장 동향 및 비즈니스 기회 등 나노캐리어 시장 통계를 제공하는 The Business Research Company의 최신 보고서 시리즈 중 하나입니다. 이 나노캐리어 시장 조사 보고서는 업계의 현재와 미래 시나리오를 자세히 분석하여 필요한 모든 것을 완벽한 관점으로 제공합니다.
맞춤형 의료에 대한 수요 증가는 나노캐리어 시장의 큰 성장을 가속할 것으로 예측됩니다. 맞춤의료란 환자 개개인의 고유한 유전자, 바이오마커, 분자적 특성에 맞는 치료를 하는 것을 말합니다. 이러한 추세는 특히 암 치료에서 더욱 가속화되고 있으며, 의사는 환자의 유전자 프로파일을 기반으로 치료 동향을 맞춤화하여 효능을 향상시키고 부작용을 최소화할 수 있습니다. 나노캐리어는 약물을 특정 표적에 직접 전달하고, 방출을 조절하며, 생체 이용률을 높이고, 개별화된 병용요법을 가능하게 함으로써 맞춤의료에서 중요한 역할을 하고 있습니다. 예를 들어 2024년 2월 미국 비영리단체인 맞춤형 의료연합(Personalized Medicine Coalition)은 FDA가 2023년 희귀질환에 대한 16개의 새로운 개인맞춤형 치료제를 승인했다고 보고했습니다. 그 결과, 맞춤형 의료에 대한 수요 증가가 나노캐리어 시장의 성장을 주도하고 있습니다.
나노캐리어 시장의 주요 기업은 표적 약물전달 및 치료 효과를 높이기 위해 첨단 지질 나노입자 제제 개발에 주력하고 있습니다. 지질 나노입자 기술은 약물이나 유전자 치료제를 특정 세포나 조직에 안전하고 효율적으로 전달하기 위해 설계된 나노 크기의 지방 기반 캐리어입니다. 예를 들어 미국에 본사를 둔 생명공학 기업 Cytiva는 2023년 7월에 NanoAssemblr 상업용 제제 시스템을 출시했습니다. 이 완전 자동화된 일회용 플랫폼은 지질 나노입자(LNP) 의약품의 엔드투엔드 임상 및 상업적 제조를 위해 설계되었습니다. 이 시스템은 Cytiva의 NxGen 기술을 채택하여 일관되고 재현성 있는 혼합을 실현함으로써 연구부터 대규모 생산까지 품질을 보장합니다. 또한 단일 사용 유체 경로를 통해 오염 위험을 줄이고, 하나의 시설에서 효율적인 다품종 생산을 지원합니다. 또한 이 플랫폼에는 워크플로우를 자동화하고 전자 배치 기록을 가능하게 하는 규제 준수 소프트웨어가 포함되어 있으며, mRNA 백신, 유전자 치료제, 암 백신의 제조를 간소화합니다.
2024년 8월, 미국 생명과학 플랫폼 기업 VION Biosciences LLC는 Echelon Biosciences Inc.를 비공개 금액으로 인수했습니다. 이번 인수는 mRNA 및 유전자 기반 바이오 치료제를 제공하는 데 주력하는 고객을 지원하는 VION의 역량을 강화하는 것을 목표로 하고 있습니다. 이번 인수를 통해 비온의 신약개발 및 전임상 역량이 강화되는 동시에 의약품 제조 분야로의 진출이 용이해집니다. 에슈론 바이오사이언스는 mRNA 기반 치료제 전달에 필수적인 지질 나노입자(LNP)를 제조하는 생명공학 기업입니다.
나노캐리어 시장은 고분자 나노입자, 나노결정, 탄소나노튜브, 엑소좀, 양자점 매출로 구성되어 있습니다. 이 시장의 가치는 '팩토리 게이트' 가치, 즉 상품 제조업체 또는 공급업체가 다른 사업체(다운스트림 제조업체, 도매업체, 유통업체, 소매업체 포함) 또는 최종 고객에게 직접 판매한 상품의 가치입니다. 이 시장에서 상품의 가치에는 상품을 만든 사람이 판매하는 관련 서비스도 포함됩니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세 및 Covid와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 나노캐리어 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 용도 산업의 분석
세계의 나노캐리어 시장 : 성장률 분석
세계의 나노캐리어 시장 실적 : 규모와 성장, 2019-2024
세계의 나노캐리어 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 나노캐리어 : TAM(Total Addressable Market)
제6장 시장 세분화
세계의 나노캐리어 시장 : 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
고분자 나노캐리어
지질 기반 나노캐리어
무기 나노캐리어
기타 유형
세계의 나노캐리어 시장 : 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
약물전달
진단약
백신
유전자 치료
기타 용도
세계의 나노캐리어 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제약 및 바이오테크놀러지 기업
병원 및 클리닉
연구기관
기타 최종사용자
세계의 나노캐리어 시장 : 서브 세분화 고분자 나노캐리어, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
폴리유산 나노입자
폴리유산 코글리콜산 나노입자
키토산 나노입자
젤라틴 나노입자
폴리카프로락톤 나노입자
세계의 나노캐리어 시장 : 서브 세분화 지질 기반 나노캐리어, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
고체 지질 나노입자
나노 구조 지질 캐리어
리포솜
나노에멀전
자기 유화형 약물전달 시스템
세계의 나노캐리어 시장 : 서브 세분화 무기 나노캐리어, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
금 나노입자
은 나노입자
실리카 나노입자
자성 나노입자
양자점
세계의 나노캐리어 시장 : 서브 세분화 기타 유형, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
덴드리머
단백질 기반 나노캐리어
탄소나노튜브
나노 결정
엑소좀
제7장 지역별·국가별 분석
세계의 나노캐리어 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 나노캐리어 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
나노캐리어 시장 : 경쟁 구도
나노캐리어 시장 : 기업 개요
F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
Novartis AG Overview, Products and Services, Strategy and Financial Analysis
Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
Nanocarriers are nanoscale delivery systems specifically designed to transport drugs, genes, or other therapeutic agents with high precision, ensuring they reach the targeted cells or tissues within the body. These carriers enhance the stability and bioavailability of therapeutic compounds, provide controlled and sustained release, and reduce the risk of side effects by limiting exposure to healthy tissues.
The primary categories of nanocarriers include polymeric nanocarriers, lipid based nanocarriers, inorganic nanocarriers, and others. Polymeric nanocarriers are nanoscale polymer based systems created to deliver drugs or therapeutic agents effectively to specific sites in the body. They are applied in areas such as drug delivery, diagnostics, vaccines, gene therapy, and more, supporting end users such as pharmaceutical and biotechnology companies, hospitals and clinics, research institutes, and other organizations.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.
The nanocarriers market research report is one of a series of new reports from The Business Research Company that provides nanocarriers market statistics, including nanocarriers industry global market size, regional shares, competitors with a nanocarriers market share, detailed nanocarriers market segments, market trends and opportunities, and any further data you may need to thrive in the nanocarriers industry. This nanocarriers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The nanocarriers market size has grown rapidly in recent years. It will grow from $9.79 billion in 2024 to $11.61 billion in 2025 at a compound annual growth rate (CAGR) of 18.5%. The growth during the historic period can be attributed to the rising prevalence of chronic and oncologic diseases, greater approvals of targeted and personalized therapies, expansion of national immunization programs and booster initiatives, progress in biopharmaceutical research and development, and increasing healthcare spending.
The nanocarriers market size is expected to see rapid growth in the next few years. It will grow to $22.67 billion in 2029 at a compound annual growth rate (CAGR) of 18.2%. The growth during the forecast period can be attributed to the expanding aging population, continued increase in lifestyle related diseases, rising use of metal and metallic oxide particles, growing focus on personalized medicine, and greater participation in clinical trials. Key trends in the forecast period include advancements in healthcare technologies, creation of personalized and responsive drug delivery systems, development of stimuli responsive nanocarriers, progress in 3D printing technologies, and emergence of versatile nanocarrier platforms.
The growing demand for personalized medicines is expected to drive significant growth in the nanocarriers market. Personalized medicine involves tailoring medical treatments to the unique genetic, biomarker, and molecular characteristics of each patient. This trend is gaining momentum, particularly in cancer treatment, where doctors can customize therapies based on a patient's genetic profile, improving efficacy and minimizing side effects. Nanocarriers play a critical role in personalized medicine by delivering drugs directly to specific targets, controlling their release, enhancing bioavailability, and enabling individualized combination therapies. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit, reported that the FDA approved 16 new personalized therapies for rare diseases in 2023, a sharp increase from six in 2022. As a result, the increasing demand for personalized medicines is driving the growth of the nanocarriers market.
Leading companies in the nanocarriers market are focusing on developing advanced lipid nanoparticle formulations to enhance targeted drug delivery and therapeutic effectiveness. Lipid nanoparticle technologies are nanoscale, fat-based carriers designed to safely and efficiently deliver drugs or genetic therapies to specific cells or tissues. For example, in July 2023, Cytiva, a US-based biotechnology company, launched the NanoAssemblr commercial formulation system. This fully automated, single-use platform is designed for end-to-end clinical and commercial manufacturing of lipid nanoparticle (LNP) medicines. The system uses Cytiva's NxGen technology to provide consistent, reproducible mixing, ensuring quality from research to large-scale manufacturing. It also reduces contamination risks through its single-use fluid path and supports efficient multi-product manufacturing in one facility. Additionally, the platform includes regulatory-compliant software that automates workflows and enables electronic batch records, simplifying the production of mRNA vaccines, gene therapies, and cancer vaccines.
In August 2024, VION Biosciences LLC, a US-based life sciences platform company, acquired Echelon Biosciences Inc. for an undisclosed amount. This acquisition aims to enhance VION's ability to support customers focused on delivering mRNA and gene-based biotherapeutics. The deal strengthens VION's drug discovery and preclinical capabilities while facilitating its entry into the drug manufacturing sector. Echelon Biosciences is a biotechnology company that manufactures lipid nanoparticles (LNPs), which are vital for the delivery of mRNA-based therapies.
Major players in the nanocarriers market are F. Hoffmann-La Roche Ltd, Pfizer Inc., Sanofi S.A., Novartis AG, Bristol-Myers Squibb Company, Amgen Inc., Evonik Industries AG, Matinas BioPharma Holdings Inc., Luye Pharma Group Ltd., Ascendia Pharmaceuticals Inc., Arcturus Therapeutics Holdings Inc., Nanobiotix S.A., Polymun Scientific Immunbiologische Forschung GmbH, ReCode Therapeutics Inc., Celsion Corporation, Starpharma Holdings Limited, EnGeneIC Ltd., Acuitas Therapeutics Inc., Altamira Therapeutics Ltd., Nanexa AB.
North America was the largest region in the nanocarriers market in 2024. The regions covered in nanocarriers report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the nanocarriers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The nanocarriers market consists of sales of polymeric nanoparticles, nanocrystals, carbon nanotubes, exosomes, and quantum dots. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Nanocarriers Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on nanocarriers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for nanocarriers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The nanocarriers market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type: Polymeric Nanocarriers; Lipid-Based Nanocarriers; Inorganic Nanocarriers; Other Types
2) By Application: Drug Delivery; Diagnostics; Vaccines; Gene Therapy; Other Applications
3) By End-User: Pharmaceutical And Biotechnology Companies; Hospitals And Clinics; Research Institutes; Other End-Users
Subsegments:
1) By Polymeric Nanocarriers: Nanoparticles Of Poly Lactic Acid; Nanoparticles Of Poly Lactic-Co-Glycolic Acid; Nanoparticles Of Chitosan; Nanoparticles Of Gelatin; Nanoparticles Of Polycaprolactone
2) By Lipid-Based Nanocarriers: Solid Lipid Nanoparticles; Nanostructured Lipid Carriers; Liposomes; Nanoemulsions; Self-Emulsifying Drug Delivery Systems
3) By Inorganic Nanocarriers: Gold Nanoparticles; Silver Nanoparticles; Silica Nanoparticles; Magnetic Nanoparticles; Quantum Dots
4) By Other Types: Dendrimers; Protein-Based Nanocarriers; Carbon Nanotubes; Nanocrystals; Exosomes
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Nanocarriers Market Characteristics
3. Nanocarriers Market Trends And Strategies
4. Nanocarriers Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Nanocarriers Growth Analysis And Strategic Analysis Framework
5.1. Global Nanocarriers PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Nanocarriers Market Growth Rate Analysis
5.4. Global Nanocarriers Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Nanocarriers Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Nanocarriers Total Addressable Market (TAM)
6. Nanocarriers Market Segmentation
6.1. Global Nanocarriers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Polymeric Nanocarriers
Lipid-Based Nanocarriers
Inorganic Nanocarriers
Other Types
6.2. Global Nanocarriers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Drug Delivery
Diagnostics
Vaccines
Gene Therapy
Other Applications
6.3. Global Nanocarriers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pharmaceutical And Biotechnology Companies
Hospitals And Clinics
Research Institutes
Other End-Users
6.4. Global Nanocarriers Market, Sub-Segmentation Of Polymeric Nanocarriers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Nanoparticles Of Poly Lactic Acid
Nanoparticles Of Poly Lactic-Co-Glycolic Acid
Nanoparticles Of Chitosan
Nanoparticles Of Gelatin
Nanoparticles Of Polycaprolactone
6.5. Global Nanocarriers Market, Sub-Segmentation Of Lipid-Based Nanocarriers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Solid Lipid Nanoparticles
Nanostructured Lipid Carriers
Liposomes
Nanoemulsions
Self-Emulsifying Drug Delivery Systems
6.6. Global Nanocarriers Market, Sub-Segmentation Of Inorganic Nanocarriers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Gold Nanoparticles
Silver Nanoparticles
Silica Nanoparticles
Magnetic Nanoparticles
Quantum Dots
6.7. Global Nanocarriers Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Dendrimers
Protein-Based Nanocarriers
Carbon Nanotubes
Nanocrystals
Exosomes
7. Nanocarriers Market Regional And Country Analysis
7.1. Global Nanocarriers Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Nanocarriers Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Nanocarriers Market
8.1. Asia-Pacific Nanocarriers Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Nanocarriers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Nanocarriers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Nanocarriers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Nanocarriers Market
9.1. China Nanocarriers Market Overview
9.2. China Nanocarriers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Nanocarriers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Nanocarriers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Nanocarriers Market
10.1. India Nanocarriers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Nanocarriers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Nanocarriers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Nanocarriers Market
11.1. Japan Nanocarriers Market Overview
11.2. Japan Nanocarriers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Nanocarriers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Nanocarriers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Nanocarriers Market
12.1. Australia Nanocarriers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Nanocarriers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Nanocarriers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Nanocarriers Market
13.1. Indonesia Nanocarriers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Nanocarriers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Nanocarriers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Nanocarriers Market
14.1. South Korea Nanocarriers Market Overview
14.2. South Korea Nanocarriers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Nanocarriers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Nanocarriers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Nanocarriers Market
15.1. Western Europe Nanocarriers Market Overview
15.2. Western Europe Nanocarriers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Nanocarriers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Nanocarriers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Nanocarriers Market
16.1. UK Nanocarriers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Nanocarriers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Nanocarriers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Nanocarriers Market
17.1. Germany Nanocarriers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Nanocarriers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Nanocarriers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Nanocarriers Market
18.1. France Nanocarriers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Nanocarriers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Nanocarriers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Nanocarriers Market
19.1. Italy Nanocarriers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Nanocarriers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Nanocarriers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Nanocarriers Market
20.1. Spain Nanocarriers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Nanocarriers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Nanocarriers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Nanocarriers Market
21.1. Eastern Europe Nanocarriers Market Overview
21.2. Eastern Europe Nanocarriers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Nanocarriers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Nanocarriers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Nanocarriers Market
22.1. Russia Nanocarriers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Nanocarriers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Nanocarriers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Nanocarriers Market
23.1. North America Nanocarriers Market Overview
23.2. North America Nanocarriers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Nanocarriers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Nanocarriers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Nanocarriers Market
24.1. USA Nanocarriers Market Overview
24.2. USA Nanocarriers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Nanocarriers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Nanocarriers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Nanocarriers Market
25.1. Canada Nanocarriers Market Overview
25.2. Canada Nanocarriers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Nanocarriers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Nanocarriers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Nanocarriers Market
26.1. South America Nanocarriers Market Overview
26.2. South America Nanocarriers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Nanocarriers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Nanocarriers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Nanocarriers Market
27.1. Brazil Nanocarriers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Nanocarriers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Nanocarriers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Nanocarriers Market
28.1. Middle East Nanocarriers Market Overview
28.2. Middle East Nanocarriers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Nanocarriers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Nanocarriers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Nanocarriers Market
29.1. Africa Nanocarriers Market Overview
29.2. Africa Nanocarriers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Nanocarriers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Nanocarriers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Nanocarriers Market Competitive Landscape And Company Profiles
30.1. Nanocarriers Market Competitive Landscape
30.2. Nanocarriers Market Company Profiles
30.2.1. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
31. Nanocarriers Market Other Major And Innovative Companies
